α2-Adrenergic blocker. Prepn: J. Krapcho, W. A. Lott, US 2979511 (1961 to Olin Mathieson); and confirmation of structure: C. B. Chapleo, P. L. Myers, Tetrahedron Lett. 22, 4839 (1981). Structure-activity study: C. B. Chapleo et al., J. Med. Chem. 26, 823 (1983). Pharmacology: H. Dabiré, J. Pharmacol. 17, 113 (1986). Clinical evaluation in progressive supranuclear palsy: D. G. Cole, J. H. Growdon, J. Neural Transm. Suppl. 42, 283 (1994); as adjunct to fluphenazine in schizophrenia: R. E. Litman et al., Br. J. Psychiatry 168, 571 (1996).
Antiparkinsonian.
α-Adrenergic Blocker; Antiparkinsonian